Mn Services Vermogensbeheer B.V. Has $63.65 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Mn Services Vermogensbeheer B.V. boosted its position in shares of Danaher Co. (NYSE:DHR) by 2.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 277,300 shares of the conglomerate’s stock after purchasing an additional 5,800 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Danaher were worth $63,654,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Kentucky Retirement Systems Insurance Trust Fund lifted its holdings in shares of Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock valued at $4,874,000 after buying an additional 2,202 shares during the last quarter. Fort Pitt Capital Group LLC lifted its stake in Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after acquiring an additional 7,421 shares during the last quarter. ORG Partners LLC grew its position in Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after acquiring an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. increased its stake in shares of Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after purchasing an additional 2,465 shares during the last quarter. Finally, Generate Investment Management Ltd bought a new position in shares of Danaher during the 4th quarter valued at $8,044,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.5 %

Danaher stock opened at $209.27 on Thursday. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The stock has a market cap of $149.57 billion, a price-to-earnings ratio of 39.63, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. The business has a 50 day moving average price of $225.41 and a two-hundred day moving average price of $245.78. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the company earned $2.09 earnings per share. As a group, equities analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is presently 24.24%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Wells Fargo & Company decreased their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Barclays decreased their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Citigroup cut their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research report on Friday, December 13th. Finally, Robert W. Baird dropped their price target on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.